[1]
M. Joks and M. Urbaniak, “Non-pegylated liposomal doxorubicin based on treatment of diffuse large B cell lymphoma in old patient with increased cardiovascular risk – case report and review of literature”, OncoReview, vol. 8, no. 4(32), pp. 120-126, Dec. 2018.